136 related articles for article (PubMed ID: 33446531)
1. Stem cells on the ballot.
Goldstein LSB; Klein RN
Science; 2021 Jan; 371(6526):215. PubMed ID: 33446531
[No Abstract] [Full Text] [Related]
2. REGENERATIVE MEDICINE. California stem cell agency plots a race to the clinic.
Servick K
Science; 2016 Jan; 351(6268):15. PubMed ID: 26721984
[No Abstract] [Full Text] [Related]
3. Why regenerative stem cell medicine progresses slower than expected.
Rosemann A
J Cell Biochem; 2014 Dec; 115(12):2073-6. PubMed ID: 25079695
[No Abstract] [Full Text] [Related]
4. Wind-down of stem-cell institute leaves a void.
Loring JF
Nature; 2019 Aug; 572(7768):155. PubMed ID: 31391566
[No Abstract] [Full Text] [Related]
5. The California stem cell initiative: persuasion, politics, and public science.
Adelson JW; Weinberg JK
Am J Public Health; 2010 Mar; 100(3):446-51. PubMed ID: 20075315
[TBL] [Abstract][Full Text] [Related]
6. Stem cells, science, and public reasoning.
Hurlbut JB; Robert JS
J Policy Anal Manage; 2012; 31(3):707-14. PubMed ID: 22764379
[No Abstract] [Full Text] [Related]
7. [Stem cells: scientific progress and commercial tactics].
Nau JY
Rev Med Suisse; 2013 Oct; 9(400):1794-5. PubMed ID: 24187755
[No Abstract] [Full Text] [Related]
8. California's vote to revive controversial stem-cell institute sparks debate.
Subbaraman N
Nature; 2020 Nov; 587(7835):535. PubMed ID: 33199902
[No Abstract] [Full Text] [Related]
9. Stem cells: The impatient advocate.
Dolgin E
Nature; 2010 Dec; 468(7324):620-3. PubMed ID: 21124428
[No Abstract] [Full Text] [Related]
10. Expand and regularize federal funding for human pluripotent stem cell research.
Owen-Smith J; Scott CT; McCormick JB
J Policy Anal Manage; 2012; 31(3):714-22. PubMed ID: 22764380
[No Abstract] [Full Text] [Related]
11. A new paradigm for funding medical research.
Klein R
Stem Cells; 2012 Mar; 30(3):360-2. PubMed ID: 22334458
[No Abstract] [Full Text] [Related]
12. Local and global returns from research in stem cells: the case of the California Institute for Regenerative Medicine.
Alberro J
Regen Med; 2012 Jul; 7(4):605-13. PubMed ID: 22817632
[TBL] [Abstract][Full Text] [Related]
13. 2010 World Stem Cell Summit--part 1. October 4-6, 2010, Detroit, MI, USA.
Vertès A
IDrugs; 2010 Dec; 13(12):819-21. PubMed ID: 21154132
[TBL] [Abstract][Full Text] [Related]
14. California: 'the Stem Cell State'. Interview with Jonathan Thomas.
Thomas J
Regen Med; 2011 Nov; 6(6 Suppl):113-5. PubMed ID: 21999272
[TBL] [Abstract][Full Text] [Related]
15. The public, political parties, and stem-cell research.
Blendon RJ; Kim MK; Benson JM
N Engl J Med; 2011 Nov; 365(20):1853-6. PubMed ID: 22087677
[No Abstract] [Full Text] [Related]
16. Stem-cell agency faces budget dilemma.
Hayden EC
Nature; 2012 Jan; 482(7383):15. PubMed ID: 22297945
[No Abstract] [Full Text] [Related]
17. State stem cell agency floats idea of $70 million 'Alpha' clinics.
Dolgin E
Nat Med; 2013 Jul; 19(7):798. PubMed ID: 23836206
[No Abstract] [Full Text] [Related]
18. California Institute for Regenerative Medicine: accelerating stem cell therapies in California and beyond.
Trounson A
Stem Cells Transl Med; 2012 Jan; 1(1):6-8. PubMed ID: 23197633
[No Abstract] [Full Text] [Related]
19. California dreaming? A new start for regenerative medicine in the Golden State. Interview with Dr. Zach Hall.
Hall ZW
Regen Med; 2007 Jan; 2(1):25-8. PubMed ID: 17465772
[TBL] [Abstract][Full Text] [Related]
20. Stem cells: Hope on the line.
Hayden EC
Nature; 2014 Jul; 511(7507):19-21. PubMed ID: 24990726
[No Abstract] [Full Text] [Related]
[Next] [New Search]
